Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan Rule To Buy Only Local H1N1 Vaccine Criticized By Experts

This article was originally published in PharmAsia News

Executive Summary

Taiwan's decision to buy an H1N1 vaccine from the only local vaccine maker without also importing the drug is facing criticism by some experts. The government's bid system for purchases drew only one bidder, Taiwan's Adimmune, one-fifth owned by the government. Adimmune has relatively little experience compared with many foreign makers, and has yet to begin human trails on its version. The new purchase order given the company by the government seeks another 5 million doses. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts